Robert Weisman
Staff Writer at The Boston Globe
Staff writer @BostonGlobe and https://t.co/21fqgjdUcv. Tracking biotech and the life sciences wave washing over Massachusetts.
Articles
-
2 months ago |
bostonglobe.com | Amanda Gokee |Jonathan Saltzman |Robert Weisman
Budget cuts from the National Institutes of Health, the National Science Foundation, and other federal agencies have prompted pushback from the academic community but also some sober reflections on the future of the nation’s government-centered model for bankrolling biomedical research. That model has fueled breakthroughs, from magnetic resonance imaging and targeted cancer therapies, to mapping the human genome to the vaccines that helped vanquish the COVID pandemic.
-
2 months ago |
bostonglobe.com | Robert Weisman
The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, effective next Jan. 1, citing rapidly rising costs that are burdening insurers and employers. Under its new policy, Blue Cross Blue Shield of Massachusetts will continue to cover the costly medications, known as GLP-1s, in its standard health benefits when they’re prescribed for diabetes.
-
2 months ago |
bostonglobe.com | Robert Weisman
Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine for decades. McGrath, 53, was diagnosed with type 1 diabetes when she was 11. For years, before she could afford health insurance, she spent up to $300 a month for insulin. McGrath would stock up on lower-priced insulin on trips to Canada. These days, she buys a generic version for $35 a month through insurance.
-
2 months ago |
bostonglobe.com | Jonathan Saltzman |Robert Weisman
Shortly after the federal government froze $2.2 billion in federal funding to Harvard University for defying a slew of government demands, the head of Mass General Brigham said officials at the Harvard-affiliated health system believe the funding freeze shouldn’t apply to MGB.
-
2 months ago |
bostonglobe.com | Robert Weisman
Life sciences companies in Massachusetts were heartened by a single word in a Trump administration fact sheet about its new reciprocal tariffs: “Pharmaceuticals” were included on a short list — along with copper, semiconductors, and lumber — of goods exempted.
Journalists covering the same region
Irene Rotondo
Reporter at MassLive.com
Irene Rotondo primarily covers news in Boston, Massachusetts, United States and surrounding areas including Cambridge and Quincy.
Roberto Scalese
Senior Editor, Digital at WBUR-FM (Boston, MA)
Roberto Scalese primarily covers news in Boston, Massachusetts, United States and surrounding areas including Framingham.
Cailin Loesch
Host at Double Talk
Senior Editor at Scholastic
Cailin Loesch primarily covers news in the Greater Boston area including Cambridge and surrounding suburbs in Massachusetts, United States.
Solangi Sosa
Anchor at WNEU-TV (Boston, MA)
Solangi Sosa primarily covers news in the Greater Boston area including Cambridge, Somerville, and surrounding regions in Massachusetts, United States.
Lauren Young
Producer at WPRI-TV (Providence, RI)
Lauren Young primarily covers news in the Greater Boston area including Cambridge and surrounding suburbs in Massachusetts, United States.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 3K
- Tweets
- 3K
- DMs Open
- No